These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21835029)

  • 1. Identification of germline alterations of the mad homology 2 domain of SMAD3 and SMAD4 from the Ontario site of the breast cancer family registry (CFR).
    Tram E; Ibrahim-Zada I; Briollais L; Knight JA; Andrulis IL; Ozcelik H
    Breast Cancer Res; 2011 Aug; 13(4):R77. PubMed ID: 21835029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study.
    Xie W; Mertens JC; Reiss DJ; Rimm DL; Camp RL; Haffty BG; Reiss M
    Cancer Res; 2002 Jan; 62(2):497-505. PubMed ID: 11809701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer.
    Fleming NI; Jorissen RN; Mouradov D; Christie M; Sakthianandeswaren A; Palmieri M; Day F; Li S; Tsui C; Lipton L; Desai J; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Zhu HJ; Mariadason JM; Burgess AW; Busam D; Zhao Q; Strausberg RL; Gibbs P; Sieber OM
    Cancer Res; 2013 Jan; 73(2):725-35. PubMed ID: 23139211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutations in Smad proteins that inhibit signaling by the transforming growth factor beta in mammalian cells.
    Prokova V; Mavridou S; Papakosta P; Petratos K; Kardassis D
    Biochemistry; 2007 Dec; 46(48):13775-86. PubMed ID: 17994767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel PIAS-like protein hZimp10 enhances Smad transcriptional activity.
    Li X; Thyssen G; Beliakoff J; Sun Z
    J Biol Chem; 2006 Aug; 281(33):23748-56. PubMed ID: 16777850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in protein-binding hot-spots on the hub protein Smad3 differentially affect its protein interactions and Smad3-regulated gene expression.
    Schiro MM; Stauber SE; Peterson TL; Krueger C; Darnell SJ; Satyshur KA; Drinkwater NR; Newton MA; Hoffmann FM
    PLoS One; 2011; 6(9):e25021. PubMed ID: 21949838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of dihydrotestosterone on the transcriptions and expressions of Smad3 and Smad4 in LNCaP cell line].
    Gu RG; Zhou CW; Ma QZ
    Zhonghua Nan Ke Xue; 2006 Mar; 12(3):211-4. PubMed ID: 16597033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridge-1 is expressed in human breast carcinomas: silencing of Bridge-1 decreases Smad2, Smad3 and Smad4 expression in MCF-7 cells, a human breast cancer cell line.
    Banz-Jansen C; Münchow B; Diedrich K; Finas D
    Arch Gynecol Obstet; 2011 Dec; 284(6):1543-9. PubMed ID: 21448710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia.
    Yang XR; Devi BCR; Sung H; Guida J; Mucaki EJ; Xiao Y; Best A; Garland L; Xie Y; Hu N; Rodriguez-Herrera M; Wang C; Jones K; Luo W; Hicks B; Tang TS; Moitra K; Rogan PK; Dean M
    Breast Cancer Res Treat; 2017 Oct; 165(3):687-697. PubMed ID: 28664506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants of SMAD2/3/4/7 are associated with susceptibility to ulcerative colitis in a Japanese genetic background.
    Yamashita A; Inamine T; Suzuki S; Fukuda S; Unoike M; Kawafuchi Y; Machida H; Isomoto H; Nakao K; Tsukamoto K
    Immunol Lett; 2019 Mar; 207():64-72. PubMed ID: 30653987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Nodal, Cripto, SMAD3, phosphorylated SMAD3, and SMAD4 in the proliferative endometrium of women with endometriosis.
    Cruz CD; Del Puerto HL; Rocha AL; Cavallo IK; Clarizia AD; Petraglia F; Reis FM
    Reprod Sci; 2015 May; 22(5):527-33. PubMed ID: 25228630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
    Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
    Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 interacts with Smad3 and regulates Smad3-mediated TGF-beta signaling during oxidative stress responses.
    Li H; Sekine M; Seng S; Avraham S; Avraham HK
    PLoS One; 2009 Sep; 4(9):e7091. PubMed ID: 19768112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta.
    Pardali K; Kurisaki A; Morén A; ten Dijke P; Kardassis D; Moustakas A
    J Biol Chem; 2000 Sep; 275(38):29244-56. PubMed ID: 10878024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsa-miR-5582-3P regulatory effect on TGFβ signaling through targeting of TGFβ-R1, TGFβ-R2, SMAD3, and SMAD4 transcripts.
    Abedini Bakhshmand E; Mohammad Soltani B; Fasihi A; Mowla SJ
    J Cell Biochem; 2018 Dec; 119(12):9921-9930. PubMed ID: 30129155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.
    Saxena S; Chakraborty A; Kaushal M; Kotwal S; Bhatanager D; Mohil RS; Chintamani C; Aggarwal AK; Sharma VK; Sharma PC; Lenoir G; Goldgar DE; Szabo CI
    BMC Med Genet; 2006 Oct; 7():75. PubMed ID: 17018160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.
    Lee DS; Yoon SY; Looi LM; Kang P; Kang IN; Sivanandan K; Ariffin H; Thong MK; Chin KF; Mohd Taib NA; Yip CH; Teo SH
    Breast Cancer Res; 2012 Apr; 14(2):R66. PubMed ID: 22507745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline mutations of PALB2 gene in a sequential series of Chinese patients with breast cancer.
    Zhang K; Zhou J; Zhu X; Luo M; Xu C; Yu J; Deng M; Zheng S; Chen Y
    Breast Cancer Res Treat; 2017 Dec; 166(3):865-873. PubMed ID: 28825143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune regulation and therapeutic potential of the SMAD gene family in breast cancer.
    Chen Z; Wang Y; Lu X; Chen H; Kong Y; Rong L; Wang G
    Sci Rep; 2024 Mar; 14(1):6769. PubMed ID: 38514720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA3 transcription factor abrogates Smad4 transcription factor-mediated fascin overexpression, invadopodium formation, and breast cancer cell invasion.
    Sun J; He H; Pillai S; Xiong Y; Challa S; Xu L; Chellappan S; Yang S
    J Biol Chem; 2013 Dec; 288(52):36971-82. PubMed ID: 24235142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.